Across Canada, the way hospitals and health networks purchase new medical technologies is undergoing a quiet but significant transformation. Many provinces are consolidating buying power through centralized procurement bodies that rely on shared digital systems. These changes are designed to make spending more transparent and accountable, yet they also shift how early‑stage medtech firms move from pilot projects to first sales. For innovators used to dealing directly with a c
